NUWE Nuwellis, Inc. stock chart & analysis
Conviction 40HealthcareScan · Tue, Oct 27, 2026Nuwellis, Inc. (NUWE) closed at $5.37 (+73.40%) on Oct 27, 2026. Its latest daily candle is a bullish belt hold. Price is below its 50-day and below its 200-day moving average. RSI(14) 46, RS Rating 1, -99.7% from its 52-week high, -99.0% year to date. Sector: Healthcare · Electromedical & Electrotherapeutic Apparatus.
Price chart, 63 bars from Thu, Jul 30, 2026 to Tue, Oct 27, 2026. Last close $5.37, high $57.60, low $2.52.
Reddit mention data: ApeWisdom
Why NUWE moved
From the StockSetups movers recaps that covered NUWE, newest first. A recap states what was known that day.
- Close+73.4%
The most likely catalyst is a company announcement on October 27 of a published 91-patient pediatric study of its Aquadex SmartFlow system. The study is from the ULTRA-Peds registry. Nuwellis says it supports a proposed label expansion, from patients weighing 20 kg and up to those weighing 5 kg and up.
Top Stock Movers Oct 27, 2026: Why NUWE, BRAI, USGG Surged → - Premarket+177.0%
A Dailyhunt headline from earlier this morning reads "Nuwellis (NUWE) Stock Rallies 90% After Hours: Here's Why it is Trending" — confirming the move began in Wednesday's after-hours session and is continuing to accelerate into Thursday's premarket.
Premarket Stock Movers — July 30, 2026: Why NUWE, DFNS, PN, STKH & XRX Are Surging →
Financials as of Tue, Jun 30, 2026 · quarterly.
NUWE technical analysis
Trend
NUWE is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 22.4% below the 50-day ($6.92) and 97.8% below the 200-day ($247.70). ADX(14) at 20 points to a weak trend — more range than direction. It meets 1 of 8 trend-template criteria.
Momentum
RSI(14) is 46, in the bearish half of its range. MACD crossed above its signal line on the latest session. Its RS Rating of 1 puts its weighted 12-month performance ahead of about 1% of the US market.
Volume and volatility
Volume on the latest session ran 3754.3× its 20-day average. It trades about $24.7M a day on average. ATR(14) is $0.9408, 17.5% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.55) shows accumulation.
Key levels
The 52-week range is $2.52 to $1,556.07; price is 99.7% below the high and 112.7% above the low. The VWAP anchored at the 52-week high is $14.30, above price.
Performance
NUWE returned +8.6% (1 week), -21.5% (1 month), -68.4% (3 months), -98.5% (6 months), -99.5% (1 year), -99.0% (year to date).
About Nuwellis, Inc.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
Electromedical & Electrotherapeutic Apparatus · Listed 2012 · 38 employees
Recent news
- Nuwellis Jumps 47% After Pediatric Aquadex Study AnnouncementStocksToTrade · Tue, Oct 27, 2026
- What’s Going on with Penny Stock Nuwellis (NUWE) Today?TipRanks · Tue, Oct 27, 2026
- Nuwellis Announces Acceptance of Multicenter Pediatric Aquadex Study in Pediatric NephrologyYahoo Finance · Tue, Oct 27, 2026
- Form 8K Nuwellis Inc For: 23 October By Investing.comInvesting.com South Africa · Sat, Oct 24, 2026
- Nuwellis to implement one-for-nine reverse stock split effective next weekInvesting.com Nigeria · Fri, Oct 23, 2026
- Nuwellis, Inc.: 8-K filedSEC EDGAR · Fri, Oct 23, 2026
- NUWE 8-K & SEC FilingsYahoo Finance · Fri, Oct 23, 2026
- Technical Analysis of Nuwellis, Inc. (NASDAQ:NUWE)TradingView · Wed, Apr 28, 2021
Insider activity
SEC Form 4 transactions in NUWE
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Feldshon Archelle Georgiou Director · Nonstatutory Stock Option (right to buy) · 2026-04-28 | Grant | 6.74K | $0 | 2026-04-28 | 2026-04-29 |
McDonald David Director · Nonstatutory Stock Option (right to buy) · 2026-04-28 | Grant | 6.74K | $0 | 2026-04-28 | 2026-04-29 |
WALLER GREGORY D Director · Nonstatutory Stock Option (right to buy) · 2026-04-28 | Grant | 6.74K | $0 | 2026-04-28 | 2026-04-29 |
Emerson Martin J Director · Nonstatutory Stock Option (right to buy) · 2026-04-28 | Grant | 6.74K | $0 | 2026-04-28 | 2026-04-29 |
SEC filings
EDGAR filings in NUWE · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.